BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28445628)

  • 1. Characterization of four Latin American families confirms previous findings and reveals novel features of acid-labile subunit deficiency.
    Scaglia PA; Keselman AC; Braslavsky D; Martucci LC; Karabatas LM; Domené S; Gutiérrez ML; Ballerini MG; Ropelato MG; Spinola-Castro A; Siviero-Miachon AA; Tartuci JS; Rodríguez Azrak MS; Rey RA; Jasper HG; Bergadá I; Domené HM
    Clin Endocrinol (Oxf); 2017 Sep; 87(3):300-311. PubMed ID: 28445628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical characteristics and bone mineral density of homozygous, compound heterozygous and heterozygous carriers of three novel
    Işık E; Haliloglu B; van Doorn J; Demirbilek H; Scheltinga SA; Losekoot M; Wit JM
    Eur J Endocrinol; 2017 Jun; 176(6):657-667. PubMed ID: 28249955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor (IGF)-I, IGF binding protein-3 levels, and hyperinsulinemia.
    Heath KE; Argente J; Barrios V; Pozo J; Díaz-González F; Martos-Moreno GA; Caimari M; Gracia R; Campos-Barros A
    J Clin Endocrinol Metab; 2008 May; 93(5):1616-24. PubMed ID: 18303074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of the insulin-like growth factor-binding protein acid-labile subunit (ALS) of the circulating ternary complex in children with short stature.
    Domené HM; Scaglia PA; Jasper HG
    Pediatr Endocrinol Rev; 2010 Jun; 7(4):339-46. PubMed ID: 20679994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutations.
    Domené HM; Scaglia PA; Lteif A; Mahmud FH; Kirmani S; Frystyk J; Bedecarrás P; Gutiérrez M; Jasper HG
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4444-50. PubMed ID: 17726072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of pathogenicity of natural IGFALS gene variants by in silico bioinformatics tools and in vitro functional studies.
    Martucci LC; Gutiérrez ML; Karabatas LM; Scaglia PA; Rey RA; Domené HM; Jasper HG; Domené S
    Mol Cell Endocrinol; 2016 Jul; 429():19-28. PubMed ID: 27018247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous IGFALS gene variants in idiopathic short stature and normal children: impact on height and the IGF system.
    Domené HM; Scaglia PA; Martínez AS; Keselman AC; Karabatas LM; Pipman VR; Bengolea SV; Guida MC; Ropelato MG; Ballerini MG; Lescano EM; Blanco MA; Heinrich JJ; Rey RA; Jasper HG
    Horm Res Paediatr; 2013; 80(6):413-23. PubMed ID: 24335034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid-labile subunit (ALS) deficiency.
    Domené HM; Hwa V; Jasper HG; Rosenfeld RG
    Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):101-13. PubMed ID: 21396577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Homozygous Mutation of the Acid-Labile Subunit
    Poyrazoğlu Ş; Hwa V; Baş F; Dauber A; Rosenfeld R; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):432-438. PubMed ID: 30717585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit.
    van Duyvenvoorde HA; Kempers MJ; Twickler TB; van Doorn J; Gerver WJ; Noordam C; Losekoot M; Karperien M; Wit JM; Hermus AR
    Eur J Endocrinol; 2008 Aug; 159(2):113-20. PubMed ID: 18463107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences.
    Domené HM; Hwa V; Argente J; Wit JM; Camacho-Hübner C; Jasper HG; Pozo J; van Duyvenvoorde HA; Yakar S; Fofanova-Gambetti OV; Rosenfeld RG;
    Horm Res; 2009; 72(3):129-41. PubMed ID: 19729943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total absence of functional acid labile subunit, resulting in severe insulin-like growth factor deficiency and moderate growth failure.
    Hwa V; Haeusler G; Pratt KL; Little BM; Frisch H; Koller D; Rosenfeld RG
    J Clin Endocrinol Metab; 2006 May; 91(5):1826-31. PubMed ID: 16507628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of acid-labile subunit (ALS) in the modulation of GH-IGF-I action.
    Domené S; Domené HM
    Mol Cell Endocrinol; 2020 Dec; 518():111006. PubMed ID: 32861700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid-labile subunit deficiency and growth failure: description of two novel cases.
    David A; Rose SJ; Miraki-Moud F; Metherell LA; Savage MO; Clark AJ; Camacho-Hübner C
    Horm Res Paediatr; 2010; 73(5):328-34. PubMed ID: 20389102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in IGFALS, c.380T>C (p.L127P), associated with short stature, delayed puberty, osteopenia and hyperinsulinaemia in two siblings: insights into the roles of insulin growth factor-1 (IGF1).
    Hess O; Khayat M; Hwa V; Heath KE; Teitler A; Hritan Y; Allon-Shalev S; Tenenbaum-Rakover Y
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):838-44. PubMed ID: 23488611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children.
    Mandel SH; Moreland E; Rosenfeld RG; Gargosky SE
    Endocrine; 1997 Dec; 7(3):351-60. PubMed ID: 9657073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoblot studies of the acid-labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after long-term therapy with GH or IGF-I respectively.
    Labarta JI; Gargosky SE; Simpson DM; Lee PD; Argente J; Guevara-Aguirre J; Rosenfeld RG
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):657-66. PubMed ID: 9497872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of heterozygosity for acid-labile subunit (IGFALS) gene mutations on stature: results from the international acid-labile subunit consortium.
    Fofanova-Gambetti OV; Hwa V; Wit JM; Domene HM; Argente J; Bang P; Högler W; Kirsch S; Pihoker C; Chiu HK; Cohen L; Jacobsen C; Jasper HG; Haeusler G; Campos-Barros A; Gallego-Gómez E; Gracia-Bouthelier R; van Duyvenvoorde HA; Pozo J; Rosenfeld RG
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4184-91. PubMed ID: 20591980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three novel IGFALS gene mutations resulting in total ALS and severe circulating IGF-I/IGFBP-3 deficiency in children of different ethnic origins.
    Fofanova-Gambetti OV; Hwa V; Kirsch S; Pihoker C; Chiu HK; Högler W; Cohen LE; Jacobsen C; Derr MA; Rosenfeld RG
    Horm Res; 2009; 71(2):100-10. PubMed ID: 19129715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse.
    Domené HM; Bengolea SV; Jasper HG; Boisclair YR
    J Endocrinol Invest; 2005; 28(5 Suppl):43-6. PubMed ID: 16114275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.